A comprehensive look at transcription factor gene expression changes in colorectal adenomas

BMC Cancer

Volumn 14, Issue 1, 2014, Pages

  Vonlanthen, Janine ^a   Okoniewski, Michal J ^a   Menigatti, Mirco ^a   Cattaneo, Elisa ^a   Pellegrini Ochsner, Daniela ^b   Haider, Ritva ^a   Jiricny, Josef ^a   Staiano, Teresa ^c   Buffoli, Federico ^c   Marra, Giancarlo ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b TRIEMLI HOSPITAL   (Switzerland)

^c CREMONA HOSPITAL   (Italy)

Author keywords

Colorectal adenomas; DACH1; Gene expression; Transcription factors

Indexed keywords

ADENOMA; CELL TRANSFORMATION, NEOPLASTIC; CLUSTER ANALYSIS; COLORECTAL NEOPLASMS; EYE PROTEINS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; GENES, MYB; HUMANS; IMMUNOHISTOCHEMISTRY; INHIBITOR OF APOPTOSIS PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTORS, GLUCOCORTICOID; RNA, MESSENGER; TELOMERASE; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA1; TUMOR MARKERS, BIOLOGICAL;

EID: 84893020164     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-14-46     Document Type: Article

References (62)

1. Winawer SJ, Zauber AG, Fletcher RH, Stillman JS, O'Brien MJ, Levin B, Smith RA, Lieberman DA, Burt RW, Levin TR, Bond JH, Brooks D, Byers T, Hyman N, Kirk L, Thorson A, Simmang C, Johnson D, Rex DK. Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. Gastroenterology 2006, 130(6):1872-1885. 10.1053/j.gastro.2006.03.012, 16697750.
2. Stryker SJ, Wolff BG, Culp CE, Libbe SD, Ilstrup DM, MacCarty RL. Natural history of untreated colonic polyps. Gastroenterology 1987, 93(5):1009-1013.
3. Sabates-Bellver J, Van der Flier LG, de Palo M, Cattaneo E, Maake C, Rehrauer H, Laczko E, Kurowski MA, Bujnicki JM, Menigatti M, Luz J, Ranalli TV, Gomes V, Pastorelli A, Faggiani R, Anti M, Jiricny J, Clevers H, Marra G. Transcriptome profile of human colorectal adenomas. Mol Cancer Res 2007, 5(12):1263-1275. 10.1158/1541-7786.MCR-07-0267, 18171984.
4. Cattaneo E, Baudis M, Buffoli F, Bianco MA, Zorzi F, Marra G. Pathways and crossroads to colorectal cancer. Pre-Invasive Disease: Pathogenesis and Clinical Management 2011, 369-394. Springer, Fitzgerald RC.
5. Pinto D, Clevers H. Wnt, stem cells and cancer in the intestine. Biol Cell 2005, 97(3):185-196. 10.1042/BC20040094, 15715524.
6. Dang CV. MYC on the path to cancer. Cell 2012, 149(1):22-35. 10.1016/j.cell.2012.03.003, 3345192, 22464321.
7. Sansom OJ, Meniel VS, Muncan V, Phesse TJ, Wilkins JA, Reed KR, Vass JK, Athineos D, Clevers H, Clarke AR. Myc deletion rescues Apc deficiency in the small intestine. Nature 2007, 446(7136):676-679. 10.1038/nature05674, 17377531.
8. Dang CV, O'Donnell KA, Zeller KI, Nguyen T, Osthus RC, Li F. The c-Myc target gene network. Semin Cancer Biol 2006, 16(4):253-264. 10.1016/j.semcancer.2006.07.014, 16904903.
9. Ji H, Wu G, Zhan X, Nolan A, Koh C, De Marzo A, Doan HM, Fan J, Cheadle C, Fallahi M, Cleveland JL, Dang CV, Zeller KI. Cell-type independent MYC target genes reveal a primordial signature involved in biomass accumulation. PLoS One 2011, 6(10):e26057. 10.1371/journal.pone.0026057, 3198433, 22039435.
10. Lin CY, Loven J, Rahl PB, Paranal RM, Burge CB, Bradner JE, Lee TI, Young RA. Transcriptional amplification in tumor cells with elevated c-Myc. Cell 2012, 151(1):56-67. 10.1016/j.cell.2012.08.026, 3462372, 23021215.
11. Nie Z, Hu G, Wei G, Cui K, Yamane A, Resch W, Wang R, Green DR, Tessarollo L, Casellas R, Zhao K, Levens D. c-Myc is a universal amplifier of expressed genes in lymphocytes and embryonic stem cells. Cell 2012, 151(1):68-79. 10.1016/j.cell.2012.08.033, 3471363, 23021216.
12. Biggin MD. Animal transcription networks as highly connected, quantitative continua. Dev Cell 2011, 21(4):611-626. 10.1016/j.devcel.2011.09.008, 22014521.
13. Cattaneo E, Laczko E, Buffoli F, Zorzi F, Bianco MA, Menigatti M, Bartosova Z, Haider R, Helmchen B, Sabates-Bellver J, Tiwari A, Jiricny J, Marra G. Preinvasive colorectal lesion transcriptomes correlate with endoscopic morphology (polypoid vs. nonpolypoid). EMBO Mol Med 2011, 3(6):334-347. 10.1002/emmm.201100141, 3377079, 21538994.
14. Maglietta R, Liuzzi VC, Cattaneo E, Laczko E, Piepoli A, Panza A, Carella M, Palumbo O, Staiano T, Buffoli F, Andriulli A, Marra G, Ancona N. Molecular pathways undergoing dramatic transcriptomic changes during tumor development in the human colon. BMC Cancer 2012, 12:608. 10.1186/1471-2407-12-608, 3541196, 23253212.
15. Vaquerizas JM, Kummerfeld SK, Teichmann SA, Luscombe NM. A census of human transcription factors: function, expression and evolution. Nat Rev Genet 2009, 10(4):252-263. 10.1038/nrg2538, 19274049.
16. Hubbard TJ, Aken BL, Beal K, Ballester B, Caccamo M, Chen Y, Clarke L, Coates G, Cunningham F, Cutts T, Down T, Dyer SC, Fitzgerald S, Fernandez-Banet J, Graf S, Haider S, Hammond M, Herrero J, Holland R, Howe K, Howe K, Johnson N, Kahari A, Keefe D, Kokocinski F, Kulesha E, Lawson D, Longden I, Melsopp C, Megy K, et al. Ensembl 2007. Nucleic Acids Res 2007, 35(Database issue):D610-617. 1761443, 17148474.
17. Wingender E, Chen X, Hehl R, Karas H, Liebich I, Matys V, Meinhardt T, Pruss M, Reuter I, Schacherer F. TRANSFAC: an integrated system for gene expression regulation. Nucleic Acids Res 2000, 28(1):316-319. 10.1093/nar/28.1.316, 102445, 10592259.
18. Nikolsky Y, Ekins S, Nikolskaya T, Bugrim A. A novel method for generation of signature networks as biomarkers from complex high throughput data. Toxicol Lett 2005, 158(1):20-29. 10.1016/j.toxlet.2005.02.004, 15871913.
19. Ferreira JA, Zwinderman A. Approximate sample size calculations with microarray data: an illustration. Stat Appl Genet Mol Biol 2006, 5:25.
20. Truninger K, Menigatti M, Luz J, Russell A, Haider R, Gebbers JO, Bannwart F, Yurtsever H, Neuweiler J, Riehle HM, Cattaruzza MS, Heinimann K, Schär P, Jiricny J, Marra G. Immunohistochemical analysis reveals high frequency of PMS2 defects in colorectal cancer. Gastroenterology 2005, 128(5):1160-1171. 10.1053/j.gastro.2005.01.056, 15887099.
21. Menigatti M, Cattaneo E, Sabates-Bellver J, Ilinsky VV, Went P, Buffoli F, Marquez VE, Jiricny J, Marra G. The protein tyrosine phosphatase receptor type R gene is an early and frequent target of silencing in human colorectal tumorigenesis. Mol Cancer 2009, 8:124. 10.1186/1476-4598-8-124, 2801661, 20015382.
22. Barrett T, Troup DB, Wilhite SE, Ledoux P, Evangelista C, Kim IF, Tomashevsky M, Marshall KA, Phillippy KH, Sherman PM, Muertter RN, Holko M, Ayanbule O, Yefanov A, Soboleva A. NCBI GEO: archive for functional genomics data sets-10 years on. Nucleic Acids Res 2011, 39(Database issue):D1005-1010. 3013736, 21097893.
23. di Pietro M, Sabates Bellver J, Menigatti M, Bannwart F, Schnider A, Russell A, Truninger K, Jiricny J, Marra G. Defective DNA mismatch repair determines a characteristic transcriptional profile in proximal colon cancers. Gastroenterology 2005, 129(3):1047-1059. 10.1053/j.gastro.2005.06.028, 16143142.
24. Schwanhausser B, Busse D, Li N, Dittmar G, Schuchhardt J, Wolf J, Chen W, Selbach M. Global quantification of mammalian gene expression control. Nature 2011, 473(7347):337-342. 10.1038/nature10098, 21593866.
25. Mardon G, Solomon NM, Rubin GM. Dachshund encodes a nuclear protein required for normal eye and leg development in Drosophila. Development 1994, 120(12):3473-3486.
26. Chen R, Amoui M, Zhang Z, Mardon G. Dachshund and eyes absent proteins form a complex and function synergistically to induce ectopic eye development in Drosophila. Cell 1997, 91(7):893-903. 10.1016/S0092-8674(00)80481-X, 9428513.
27. Li X, Oghi KA, Zhang J, Krones A, Bush KT, Glass CK, Nigam SK, Aggarwal AK, Maas R, Rose DW, Rosenfeld MG. Eya protein phosphatase activity regulates Six1-Dach-Eya transcriptional effects in mammalian organogenesis. Nature 2003, 426(6964):247-254. 10.1038/nature02083, 14628042.
28. Li X, Perissi V, Liu F, Rose DW, Rosenfeld MG. Tissue-specific regulation of retinal and pituitary precursor cell proliferation. Science 2002, 297(5584):1180-1183.
29. Lee JW, Kim HS, Kim S, Hwang J, Kim YH, Lim GY, Sohn WJ, Yoon SR, Kim JY, Park TS, Park KM, Ryoo ZY, Lee S. DACH1 regulates cell cycle progression of myeloid cells through the control of cyclin D, Cdk 4/6 and p21Cip1. Biochem Biophys Res Commun 2012, 420(1):91-95. 10.1016/j.bbrc.2012.02.120, 22405764.
30. Wu K, Yang Y, Wang C, Davoli MA, D'Amico M, Li A, Cveklova K, Kozmik Z, Lisanti MP, Russell RG, Cvekl A, Pestell RG. DACH1 inhibits transforming growth factor-beta signaling through binding Smad4. J Biol Chem 2003, 278(51):51673-51684. 10.1074/jbc.M310021200, 14525983.
31. Wu K, Liu M, Li A, Donninger H, Rao M, Jiao X, Lisanti MP, Cvekl A, Birrer M, Pestell RG. Cell fate determination factor DACH1 inhibits c-Jun-induced contact-independent growth. Mol Biol Cell 2007, 18(3):755-767. 10.1091/mbc.E06-09-0793, 1805093, 17182846.
32. Wu K, Li A, Rao M, Liu M, Dailey V, Yang Y, Di Vizio D, Wang C, Lisanti MP, Sauter G, Russell RG, Cvekl A, Pestell RG. DACH1 is a cell fate determination factor that inhibits cyclin D1 and breast tumor growth. Mol Cell Biol 2006, 26(19):7116-7129. 10.1128/MCB.00268-06, 1592900, 16980615.
33. Munoz J, Stange DE, Schepers AG, van de Wetering M, Koo BK, Itzkovitz S, Volckmann R, Kung KS, Koster J, Radulescu S, Myant K, Versteeg R, Sansom OJ, van Es JH, Barker N, van Oudenaarden A, Mohammed S, Heck AJ, Clevers H. The Lgr5 intestinal stem cell signature: robust expression of proposed quiescent ' + 4' cell markers. Embo J 2012, 31(14):3079-3091. 10.1038/emboj.2012.166, 3400017, 22692129.
34. Bernstein BE, Mikkelsen TS, Xie X, Kamal M, Huebert DJ, Cuff J, Fry B, Meissner A, Wernig M, Plath K, Jaenisch R, Wagschal A, Feil R, Schreiber SL, Lander ES. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 2006, 125(2):315-326. 10.1016/j.cell.2006.02.041, 16630819.
35. Govindan R, Ding L, Griffith M, Subramanian J, Dees ND, Kanchi KL, Maher CA, Fulton R, Fulton L, Wallis J, Chen K, Walker J, McDonald S, Bose R, Ornitz D, Xiong D, You M, Dooling DJ, Watson M, Mardis ER, Wilson RK. Genomic landscape of non-small cell lung cancer in smokers and never-smokers. Cell 2012, 150(6):1121-1134. 10.1016/j.cell.2012.08.024, 3656590, 22980976.
36. Watanabe A, Ogiwara H, Ehata S, Mukasa A, Ishikawa S, Maeda D, Ueki K, Ino Y, Todo T, Yamada Y, Fukuyama M, Saito N, Miyazono K, Aburatani H. Homozygously deleted gene DACH1 regulates tumor-initiating activity of glioma cells. Proc Natl Acad Sci U S A 2011, 108(30):12384-12389. 10.1073/pnas.0906930108, 3145721, 21750150.
37. Chen K, Wu K, Cai S, Zhang W, Zhou J, Wang J, Ertel A, Li Z, Rui H, Quong A, Lisanti MP, Tozeren A, Tanes C, Addya S, Gormley M, Wang C, McMahon SB, Pestell RG. Dachshund binds p53 to block the growth of lung adenocarcinoma cells. Cancer Res 2013, 73(11):3262-3274. 10.1158/0008-5472.CAN-12-3191, 23492369.
38. Popov VM, Wu K, Zhou J, Powell MJ, Mardon G, Wang C, Pestell RG. The Dachshund gene in development and hormone-responsive tumorigenesis. Trends Endocrinol Metab 2010, 21(1):41-49. 10.1016/j.tem.2009.08.002, 2818438, 19896866.
39. Sunde JS, Donninger H, Wu K, Johnson ME, Pestell RG, Rose GS, Mok SC, Brady J, Bonome T, Birrer MJ. Expression profiling identifies altered expression of genes that contribute to the inhibition of transforming growth factor-beta signaling in ovarian cancer. Cancer Res 2006, 66(17):8404-8412. 10.1158/0008-5472.CAN-06-0683, 16951150.
40. Lee S, Chen J, Zhou G, Shi RZ, Bouffard GG, Kocherginsky M, Ge X, Sun M, Jayathilaka N, Kim YC, Emmanuel N, Bohlander SK, Minden M, Kline J, Ozer O, Larson RA, LeBeau MM, Green ED, Trent J, Karrison T, Liu PP, Wang SM, Rowley JD. Gene expression profiles in acute myeloid leukemia with common translocations using SAGE. Proc Natl Acad Sci U S A 2006, 103(4):1030-1035. 10.1073/pnas.0509878103, 1347995, 16418266.
41. Lee JW, Kim HS, Hwang J, Kim YH, Lim GY, Sohn WJ, Yoon SR, Kim JY, Park TS, Oh SH, Park KM, Choi SU, Ryoo ZY, Lee S. Regulation of HOXA9 activity by predominant expression of DACH1 against C/EBPalpha and GATA-1 in myeloid leukemia with MLL-AF9. Biochem Biophys Res Commun 2012, 426(3):299-305. 10.1016/j.bbrc.2012.08.048, 22902925.
42. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011, 144(5):646-674. 10.1016/j.cell.2011.02.013, 21376230.
43. Massague J. TGFbeta in Cancer. Cell 2008, 134(2):215-230. 10.1016/j.cell.2008.07.001, 3512574, 18662538.
44. Donate LE, Blasco MA. Telomeres in cancer and ageing. Philos Trans R Soc Lond B Biol Sci 2011, 366(1561):76-84. 10.1098/rstb.2010.0291, 3001316, 21115533.
45. Hunter AM, LaCasse EC, Korneluk RG. The inhibitors of apoptosis (IAPs) as cancer targets. Apoptosis 2007, 12(9):1543-1568. 10.1007/s10495-007-0087-3, 17573556.
46. Ramsay RG, Gonda TJ. MYB function in normal and cancer cells. Nat Rev Cancer 2008, 8(7):523-534. 10.1038/nrc2439, 18574464.
47. Lind GE, Kleivi K, Meling GI, Teixeira MR, Thiis-Evensen E, Rognum TO, Lothe RA. ADAMTS1, CRABP1, and NR3C1 identified as epigenetically deregulated genes in colorectal tumorigenesis. Cell Oncol 2006, 28(5-6):259-272.
48. Daniel P, Wagrowska-Danilewicz M, Danilewicz M, Stasikowska O, Malecka-Panas E. Transforming growth factor beta 1 and metalloproteinase-9 overexpression in colorectal cancer (CC) and adenoma. Int J Colorectal Dis 2007, 22(10):1165-1172. 10.1007/s00384-007-0296-9, 17394006.
49. Hawinkels LJ, Verspaget HW, van der Reijden JJ, van der Zon JM, Verheijen JH, Hommes DW, Lamers CB, Sier CF. Active TGF-beta1 correlates with myofibroblasts and malignancy in the colorectal adenoma-carcinoma sequence. Cancer Sci 2009, 100(4):663-670. 10.1111/j.1349-7006.2009.01100.x, 19462508.
50. Bellone G, Gramigni C, Vizio B, Mauri FA, Prati A, Solerio D, Dughera L, Ruffini E, Gasparri G, Camandona M. Abnormal expression of Endoglin and its receptor complex (TGF-beta1 and TGF-beta receptor II) as early angiogenic switch indicator in premalignant lesions of the colon mucosa. Int J Oncol 2010, 37(5):1153-1165.
51. Siegel PM, Massague J. Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer. Nat Rev Cancer 2003, 3(11):807-821. 10.1038/nrc1208, 14557817.
52. Masunaga R, Kohno H, Dhar DK, Kotoh T, Tabara H, Tachibana M, Kubota H, Nagasue N. Enhanced apoptosis and transforming growth factor-beta1 expression in colorectal adenomas and carcinomas after Sulindac therapy. Dis Colon Rectum 2001, 44(7):1008-1015. 10.1007/BF02235490, 11496082.
53. Kawasaki H, Toyoda M, Shinohara H, Okuda J, Watanabe I, Yamamoto T, Tanaka K, Tenjo T, Tanigawa N. Expression of survivin correlates with apoptosis, proliferation, and angiogenesis during human colorectal tumorigenesis. Cancer 2001, 91(11):2026-2032. 10.1002/1097-0142(20010601)91:11<2026::AID-CNCR1228>3.0.CO;2-E, 11391581.
54. Lin LJ, Zheng CQ, Jin Y, Ma Y, Jiang WG, Ma T. Expression of survivin protein in human colorectal carcinogenesis. World J Gastroenterol 2003, 9(5):974-977.
55. Parfitt JR, Driman DK. Survivin and hedgehog protein expression in serrated colorectal polyps: an immunohistochemical study. Hum Pathol 2007, 38(5):710-717. 10.1016/j.humpath.2006.12.004, 17391730.
56. Hernandez JM, Farma JM, Coppola D, Hakam A, Fulp WJ, Chen DT, Siegel EM, Yeatman TJ, Shibata D. Expression of the antiapoptotic protein survivin in colon cancer. Clin Colorectal Cancer 2011, 10(3):188-193. 10.1016/j.clcc.2011.03.014, 21855041.
57. Clark AR, Belvisi MG. Maps and legends: the quest for dissociated ligands of the glucocorticoid receptor. Pharmacol Ther 2012, 134(1):54-67. 10.1016/j.pharmthera.2011.12.004, 22212616.
58. Ahlquist T, Lind GE, Costa VL, Meling GI, Vatn M, Hoff GS, Rognum TO, Skotheim RI, Thiis-Evensen E, Lothe RA. Gene methylation profiles of normal mucosa, and benign and malignant colorectal tumors identify early onset markers. Mol Cancer 2008, 7:94. 10.1186/1476-4598-7-94, 2639620, 19117505.
59. Ernst M, Ramsay RG. Colorectal cancer mouse models: integrating inflammation and the stroma. J Gastroenterol Hepatol 2012, 27(1):39-50. 10.1111/j.1440-1746.2011.06883.x, 22188027.
60. Ciznadija D, Tothill R, Waterman ML, Zhao L, Huynh D, Yu RM, Ernst M, Ishii S, Mantamadiotis T, Gonda TJ, Ramsay RG, Malaterre J. Intestinal adenoma formation and MYC activation are regulated by cooperation between MYB and Wnt signaling. Cell Death Differ 2009, 16(11):1530-1538. 10.1038/cdd.2009.94, 19609274.
61. Kolquist KA, Ellisen LW, Counter CM, Meyerson M, Tan LK, Weinberg RA, Haber DA, Gerald WL. Expression of TERT in early premalignant lesions and a subset of cells in normal tissues. Nat Genet 1998, 19(2):182-186. 10.1038/554, 9620778.
62. Terrin L, Rampazzo E, Pucciarelli S, Agostini M, Bertorelle R, Esposito G, DelBianco P, Nitti D, De Rossi A. Relationship between tumor and plasma levels of hTERT mRNA in patients with colorectal cancer: implications for monitoring of neoplastic disease. Clin Cancer Res 2008, 14(22):7444-7451. 10.1158/1078-0432.CCR-08-0478, 19010861.